0 Comments
0 Shares
256 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Large Molecule Drug Substance CDMO Market: Advancements in Biologics ProductionAccording to a new report by Polaris Market Research, the global large molecule drug substance CDMO market was valued at USD 53.79 billion in 2025 and is projected to reach USD 102.36 billion by 2034, expanding at a CAGR of 7.41% over the forecast period. Growt0068 is underpinned by rising global approvals of biologic drugs, increasing healthcare expenditure, and accelerating adoption...0 Comments 0 Shares 558 Views 0 Reviews
-
Large Molecule Drug Substance CDMO Market: Advancements in Biologics ProductionAccording to a new report by Polaris Market Research, the global large molecule drug substance CDMO market was valued at USD 53.79 billion in 2025 and is projected to reach USD 102.36 billion by 2034, expanding at a CAGR of 7.41% over the forecast period. Growt0068 is underpinned by rising global approvals of biologic drugs, increasing healthcare expenditure, and accelerating adoption...0 Comments 0 Shares 549 Views 0 Reviews
-
U.S. Large Molecule Drug Substance CDMO Market: Innovative Bioprocess Solutions Strengthen U.S. Supply SecurityIn an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Comments 0 Shares 633 Views 0 Reviews
-
Why Biopharma Companies Are Partnering with CDMOs for Large Molecule ManufacturingThe U.S. large molecule drug substance CDMO market reached a valuation of USD 12.34 billion in 2024 and is expected to grow at a CAGR of 7.5% between 2025 and 2034, reflecting strong demand across multiple product, application, and end-use segments. The market’s expansion is inseparably linked to the evolving structure of biologics manufacturing, marked by rapid innovation cycles, rising...0 Comments 0 Shares 146 Views 0 Reviews